









Mercado
/
Acciones
/
nasdaq-neog
/

Neogen Corp

NEOG

5.670USD

+0.210+3.85%

Cierre 09/18, 16:00（ET）Cotizaciones retrasadas 15 min

1.23BCap. mercado

PérdidaP/E TTM



Neogen Corp

5.670

+0.210+3.85%

Descripción general Compañía Finanzas Análisis

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.

Información de la empresa

Símbolo de cotizaciónNEOG

Nombre de la empresaNeogen Corp

Fecha de salida a bolsaAug 23, 1989

Director ejecutivoMr. Mikhael Nassif

Número de empleados2974

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 23

Dirección620 Lesher Pl

CiudadLANSING

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal48912

Teléfono15173729200

Sitio Webhttps://www.neogen.com/

Símbolo de cotizaciónNEOG

Fecha de salida a bolsaAug 23, 1989

Director ejecutivoMr. Mikhael Nassif

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

69.78K

-43.81%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

44.17K

-45.09%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

36.21K

+1.75%

Ms. Aashima Gupta

Independent Director

21.92K

-21.70%

Dr. Catherine E. Woteki, Ph.D.

Independent Director

13.24K

Dr. Ronald D. Green, Ph.D.

Independent Director

12.78K

Ms. Andrea F. Wainer

Independent Director

6.09K

Mr. Thierry Bernard

Independent Director

5.62K

Mr. Mikhael Nassif

President, Chief Executive Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. James C. (Jim) Borel

Independent Chairman of the Board

90.47K

Mr. David Hartman Naemura

Chief Financial Officer, Chief Operating Officer

69.78K

-43.81%

Dr. Amy M. Rocklin, Ph.D.

Chief Legal & Compliance Officer

44.17K

-45.09%

Dr. William T. (Bill) Boehm, Ph.D.

Independent Director

36.21K

+1.75%

Ms. Aashima Gupta

Independent Director

21.92K

-21.70%

Dr. Catherine E. Woteki, Ph.D.

Independent Director

13.24K

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Otro

27.41M

12.41%

Por regiónUSD

Nombre

Ganancia

Proporción

Domestic

115.36M

52.21%

International

105.61M

47.79%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Culture Media & Other

77.74M

35.18%

Bacterial & General Sanitation

39.88M

18.05%

Rodenticides, Insecticides & Disinfectants

35.64M

16.13%

Genomics Services

22.70M

10.27%

Natural Toxins, Allergens & Drug Residues

17.59M

7.96%

Otro

27.41M

12.41%

Estadísticas de accionistas

Actualizado: mar., 19 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

12.68%

The Vanguard Group, Inc.

10.83%

Clarkston Capital Partners, LLC

6.45%

Gates Capital Management, Inc.

5.89%

Southpoint Capital Advisors LP

4.60%

Otro

59.55%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

12.68%

The Vanguard Group, Inc.

10.83%

Clarkston Capital Partners, LLC

6.45%

Gates Capital Management, Inc.

5.89%

Southpoint Capital Advisors LP

4.60%

Otro

59.55%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

48.43%

Investment Advisor/Hedge Fund

36.90%

Hedge Fund

15.85%

Research Firm

4.89%

Sovereign Wealth Fund

4.26%

Pension Fund

1.51%

Individual Investor

0.66%

Bank and Trust

0.55%

Private Equity

0.29%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

720

240.23M

110.60%

-42.75M

2025Q1

753

280.62M

129.30%

-9.42M

2024Q4

764

265.86M

122.55%

-15.84M

2024Q3

778

258.29M

119.19%

-21.39M

2024Q2

791

255.45M

117.89%

-8.15M

2024Q1

783

241.86M

111.66%

-5.94M

2023Q4

783

234.38M

108.27%

-1.28M

2023Q3

770

225.33M

104.20%

-18.20M

2023Q2

761

232.20M

107.41%

-2.78M

2023Q1

759

225.00M

104.19%

-1.65M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

28.62M

13.19%

+5.44M

+23.46%

Mar 31, 2025

The Vanguard Group, Inc.

23.51M

10.83%

+1.91M

+8.86%

Mar 31, 2025

Clarkston Capital Partners, LLC

6.28M

2.89%

+3.41M

+118.93%

Mar 31, 2025

Gates Capital Management, Inc.

9.16M

4.22%

+9.16M

Mar 31, 2025

William Blair Investment Management, LLC

13.56M

6.25%

-787.83K

-5.49%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

8.44M

3.89%

+1.50M

+21.56%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

14.81M

6.82%

-2.67M

-15.27%

Mar 31, 2025

State Street Global Advisors (US)

8.61M

3.97%

+282.73K

+3.40%

Mar 31, 2025

Mackenzie Investments

7.76M

3.57%

-67.86K

-0.87%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

Federated Hermes MDT Small Cap Core ETF

0.48%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Inspire Small/Mid Cap ESG ETF

0.24%

Invesco S&P SmallCap 600 Pure Value ETF

0.2%

Amplify Etho Climate Leadership U.S. ETF

0.17%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.1%

iShares ESG Select Screened S&P Small-Cap ETF

0.09%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.07%

JPMorgan BetaBuilders US Small Cap Equity ETF

0.06%

Proshares Ultra Russell 2000

0.04%

Federated Hermes MDT Small Cap Core ETF

Proporción0.48%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.43%

Inspire Small/Mid Cap ESG ETF

Proporción0.24%

Invesco S&P SmallCap 600 Pure Value ETF

Proporción0.2%

Amplify Etho Climate Leadership U.S. ETF

Proporción0.17%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

Proporción0.1%

iShares ESG Select Screened S&P Small-Cap ETF

Proporción0.09%

SPDR SSGA US Small Cap Low Volatility Index ETF

Proporción0.07%

JPMorgan BetaBuilders US Small Cap Equity ETF

Proporción0.06%

Proshares Ultra Russell 2000

Proporción0.04%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

May 12, 2021

Split

1→2

Fecha

Tipo

Relación

May 12, 2021

Split

1→2

KeyAI

